3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
32
Myelodysplastic Syndromes
27
Multiple Myeloma
20
Recurrence
19
Lymphoma, Non-Hodgkin
15
Lymphoma, B-Cell
14
Lymphoma
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Ovarian Neoplasms
12
Hematologic Neoplasms
12
Melanoma
11
Pancreatic Neoplasms
10
Myeloproliferative Disorders
10
Burkitt Lymphoma
10
Leukemia
9
Hodgkin Disease
9
Stomach Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia, Biphenotypic, Acute
8
Neoplasms
7
Leukemia, Myelomonocytic, Chronic
7
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
6
Osteosarcoma
6
Neuroblastoma
6
Neoplasm Metastasis
6
Lymphoma, Mantle-Cell
6
Lymphoma, Follicular
6
Interventions
Carboplatin
6
Radiotherapy
5
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
Pemetrexed
3
Biopsy
3
Bevacizumab
3
capmatinib
2
Radiotherapy, Conformal
2
Platinum
2
Paclitaxel
2
Ipilimumab
2
Immunoglobulin G
2
Disulfides
2
Cisplatin
2
CTLA-4 Antigen
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pegfilgrastim
1
osimertinib
1
methoxyamine
1
lazertinib
1
fludarabine phosphate
1
durvalumab
1
defactinib
1
atezolizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
fludarabine
×
90 days
×
Clear all
No trials found.